NCT00266747 - An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Anxiety Disorders

Interventions

DRUG

SR58611A

Trial Locations (7)

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Tallinn

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Bromma